Overactive bladder in the female patient: The role of estrogens

Current Urology Reports

Volumn 3, Issue 6, 2002, Pages 452-457

  Robinson, Dudley ^a   Cardozo, Linda ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Estrogen; Lower Urinary Tract; Lower Urinary Tract Symptom; Overactive Bladder; Urinary Incontinence

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR;

BLADDER DISEASE; FEMALE; HUMAN; MICTURITION DISORDER; PHYSIOLOGY; REVIEW;

ESTROGENS; FEMALE; HUMANS; RECEPTORS, ESTROGEN; URINARY BLADDER DISEASES; URINATION DISORDERS;

EID: 1842834304     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-002-0096-2     Document Type: Article

References (50)

1. Stewart WF, Corey R, Herzog AR, et al.: Prevalence of overactive bladder in women: results from the NOBLE program. Int Urogynecol J Pelvic Floor Dysfunct 2001, 12:S66.
2. Milsom I, Abrams P, Cardozo L, et al.: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001, 87:760–766. A large epidemiologic study examining the incidence of LUTS associated with OAB in 16,776 patients in Europe. DOI: 10.1046/j.1464-410x.2001.02228.x
3. Iosif C, Bekassy Z: Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynaecol Scand 1984, 63:257–260. DOI: 10.3109/00016348409155509
4. Cardozo LD, Tapp A, Versi E, et al.: The lower urinary tract in peri- and postmenopausal women. In The Urogenital Deficiency Syndrome. Bagsverd, Denmark: Novo Industri AS; 1987:10–17.
5. Thomas TM, Plymat KR, Blannin J, Meade TW: Prevalence of urinary incontinence. Br Med J 1980, 281:1243–1245.
6. Iosif S, Batra S, Ek A, Astedt B: Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 1981, 141:817–820.
7. Batra SC, Iosif LS: Progesterone receptors in the female urinary tract. J Urol 1987, 138:130–134.
8. Beato M, Herrlich P, Schutz G: Steroid hormone receptors: many actors in search of a plot. Cell 1995, 83:851–857. DOI: 10.1016/0092-8674(95)90201-5
9. Green S, Walter P, Kumar V, et al.: Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986, 320:134–139. DOI: 10.1038/320134a0
10. Kuiper G, Enmark E, Pelto-Huikko M, et al.: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996, 93:5925–5930. DOI: 10.1073/pnas.93.12.5925
11. Warner M, Nilsson S, Gustafsson JA: The estrogen receptor family. Curr Opin Obstet Gynecol 1999, 11:249–254. DOI: 10.1097/00001703-199906000-00003
12. Blakeman PJ, Hilton P, Bulmer JN: Mapping estrogen and progesterone receptors throughout the female lower urinary tract. Neurourol Urodyn 1996, 15:324–325.
13. Ingelman-Sundberg A, Rosen J, Gustafsson SA: Cytosol estrogen receptors in urogenital tissues in stress incontinent women. Acta Obstet Gynecol Scand 1981, 60:585–586.
14. Bernstein IT: The pelvic floor muscles: muscle thickness in healthy and urinary-incontinent women measured by perineal ultrasonography with reference to the effect of pelvic floor training. Estrogen receptor studies. Neurourol Urodyn 1997, 16:237–275. DOI: 10.1002/(SICI)1520-6777(1997)16:4<237::AID-NAU2>3.0.CO;2-F
15. Chen GD, Oliver RH, Leung BS, et al.: Estrogen receptor a and b expression in the vaginal walls and uterosacral ligaments of premenopausal and postmenopausal women. Fertil Steril 1999, 71:1099–1102. DOI: 10.1016/S0015-0282(99)00113-2
16. Schreiter F, Fuchs P, Stockamp K: Estrogenic sensitivity of α-receptors in the urethral musculature. Urol Int 1976, 31:13–19. DOI: 10.1159/000280026
17. Pang X, Cotreau-Bibbo MM, Sant GR, Theoharides TC: Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis. Br J Urol 1995, 75:154–161.
18. Blakeman PJ, Hilton P, Bulmer JN: Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 2000, 86:32–38. This paper continues the authors’ earlier work looking at the distribution of estrogen and progesterone receptors throughout the lower urinary tract. In addition, the authors examine the effect of estrogen status hormone receptor expression. DOI: 10.1046/j.1464-410x.2000.00724.x
19. Rud T, Anderson KE, Asmussen M, et al.: Factors maintaining the urethral pressure in women. Invest Urol 1980, 17:343–347.
20. Kinn AC, Lindskog M: Estrogens and phenylpropanolamine in combination for stress incontinence. Urology 1988, 32:273–280. DOI: 10.1016/0090-4295(88)90400-1
21. Matsubara S, Okada H, Shirakawa, et al.: Estrogen levels influence β-3-adrenceptor-mediated relaxation of the female rat detrusor muscle. Urology 2002, 59:621–625. DOI: 10.1016/S0090-4295(01)01583-7
22. Smith PJB: The effect of oestrogens on bladder function in the female. In The Management of the Menopause and Postmenopausal Years. Edited by Campbell, S. Lancaster: MTP; 1976:291–298.
23. Samsioe G, Jansson I, Mellstrom D, Svandborg A: Occurrence, nature and treatment of urinary incontinence in a 70-yearold female population. Maturitas 1985, 7:335–342. DOI: 10.1016/0378-5122(85)90057-X
24. Blakeman PJ, Hilton P, Bulmer JN: Cellular proliferation in the female lower urinary tract with reference to oestrogen status. BJOG 2001, 108:813–816. This paper, using the same cohort of patients as the work on estrogen and progesterone receptor distribution, assesses cellular proliferation in the lower urinary tract with regard to hormonal status and HRT usage. DOI: 10.1016/S0306-5456(00)00210-2
25. Hextall A, Bidmead J, Cardozo L, Hooper R: Hormonal influences on the human female lower urinary tract: a prospective evaluation of the effects of the menstrual cycle on symptomatology and the results of urodynamic investigation. Neurourol Urodyn 1999, 18:282–283.
26. Van Geelen JM, Doesburg WH, Thomas CMG: Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynecol 1981, 141:384–392.
27. Benness C, Gangar K, Cardozo LD, Cutner A: Do progestogens exacerbate urinary incontinence in women on HRT? Neurourol Urodyn 1991, 10:316–318.
28. Elliot RA, Castleden CM: Effect of progestogens and oestrogens on the contractile response of rat detrusor muscle to electrical field stimulation. Clin Sci (Lond)1994, 87:337–342.
29. Maggi A, Perez J: Role of female gonadal hormones in the CNS. Life Sci 1985, 37:893–906. DOI: 10.1016/0024-3205(85)90525-9
30. Batra S, Andersson KE: Oestrogen-induced changes in muscarinic receptor density and contractile responses in the female rat urinary bladder. Acta Physiol Scand 1989, 137:135–141. DOI: 10.1111/j.1748-1716.1989.tb08729.x
31. Elliott RA, Castleden CM, Miodrag A, Kirwan P: The direct effects of diethylstilbestrol and nifedipine on the contractile responses of isolated human and rat detrusor muscles. Eur J Clin Pharmacol 1992, 43:149–155. DOI: 10.1007/BF01740662
32. Shenfield OZ, Blackmore PF, Morgan CW, et al.: Rapid effects of estriol and progesterone on tone and spontaneous rhythmic contractions of the rabbit bladder. Neurourol Urodyn 1998, 17:408–409.
33. Fantl JA, Wyman JF, Anderson RL, et al.: Postmenopausal urinary incontinence: comparison between non-estrogen and estrogen supplemented women. Obstet Gynaecol 1988, 71:823–828.
34. Rud T: The effects of estrogens and gestogens on the urethral pressure profile in urinary continent and stress incontinent women. Acta Obstet Gynecol Scand 1980, 59:365–270.
35. Ganger KF, Vyas S, Whitehead RW, et al.: Pulsitility index in the internal carotid artery in relation to transdermal oestradiol and time since the menopause. Lancet 1991, 338:839–842. DOI: 10.1016/0140-6736(91)91500-T
36. Jackson S, Vyas S: A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index. Br J Obstet Gynaecol 1998, 105:408–412.
37. Versi E, Cardozo LD: Urethral instability: diagnosis based on variations in the maximum urethral pressure in normal climacteric women. Neurourol Urodyn 1986, 5:535–541. DOI: 10.1002/nau.1930050604
38. Jackson S, Avery N, Shepherd A, et al.: The effect of estradiol on vaginal collagen in postmenopausal women with stress urinary incontinence. Neurourol Urodyn 1996, 15:327–328.
39. Ulmsten U, Ekman G, Giertz G, Malmstrom A: Different biochemical composition of connective tissue in continent and stress incontinent women. Acta Obstet Gynecol Scand 1987, 66:455–457.
40. Fantl JA, Cardozo LD, McClish DK: Estrogen therapy in the management of incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994, 83:12–18. This meta-analysis is the first attempt to try and clarify the role of estrogens in the management of urinary incontinence. Six controlled trials and 17 uncontrolled series were identified from a total of 166 papers from between 1969 and 1992.
41. Samsioe G, Jansson I, Mellstrom D, Svanborg A: Urinary incontinence in 75 year old women. Effects of oestriol. Acta Obstet Gynecol Scand 1985, 93:57.
42. Cardozo LD, Rekers H, Tapp A, et al.: Oestriol in the treatment of postmenopausal urgency: a multicentre study. Maturitas 1993, 18:47–53. DOI: 10.1016/0378-5122(93)90028-G
43. Nilsson K, Heimer G: Low dose oestradiol in the treatment of urogenital oestrogen deficiency: a pharmacokinetic and pharmacodynamic study. Maturitas 1992, 15:121–127. DOI: 10.1016/0378-5122(92)90246-Z
44. Benness C, Wise BG, Cutner A, Cardozo LD: Does low dose vaginal estradiol improve frequency and urgency in postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct 1992, 3:281.
45. Eriksen PS, Rasmussen H: Low dose 17â-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study. Eur J Obstet Gynaecol Reprod Biol 1992, 44:137–144. DOI: 10.1016/0028-2243(92)90059-8
46. Lose G, Englev E: Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG 2000, 107:1029–1034. DOI: 10.1111/j.1471-0528.2000.tb10408.x
47. Zullo MA, Oliva C, Falconi G, et al.: Efficacy of estrogen therapy in urinary incontinence. A meta-analytic study [in Italian]. Minerva Ginecol 1998, 50:199–205.
48. Grady D, Brown JS, Vittinghoff E, et al.: Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001, 97:116–120. This large, randomized, placebo-controlled study examines the effect of combined HRT on LUTS in a cohort of 1525 patients with concomitant ischemic heart disease over a 4-year period. DOI: 10.1016/S0029-7844(00)01115-7
49. Ouslander JG, Greendale GA, Uman G, et al.: Effects of oral estrogen and progestin on the lower urinary tract among female nursing home residents. J Am Geriatr Soc 2001, 49:803–807. DOI: 10.1046/j.1532-5415.2001.49160.x
50. Andersson K-E, Appell R, Awad S, et al.: Pharmacological treatment of urinary incontinence. In Incontinence: 2nd International Consultation on Incontinence. Edited by Abrams P, Cardozo L, Khoury S, Wein A. Plymouth, UK: Health Publication Ltd; 2002.